{"transactions":[{"id":691969,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-08-10T22:27:21.000Z","date":"2026-08-06","kind":"grant","planned":false,"acquired":true,"shares":56746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on August 6, 2027, and the balance of the shares shall vest in equal monthly installments over the following 36 months."}],"balance_after":56746,"derivative":{"exercise_price":16,"expiration_date":"2036-08-05","underlying":"Common Stock","underlying_shares":56746},"source":{"system":"sec-edgar","filing":"0001678152-26-000003","document":"form4-08102026_100815.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000167815226000003/form4-08102026_100815.xml","form_type":"4"}},{"id":691968,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-10T22:27:21.000Z","date":"2026-08-10","kind":"purchase","planned":false,"acquired":true,"shares":700,"price":16,"value":11200.0,"ownership":{"direct":true},"balance_after":700,"source":{"system":"sec-edgar","filing":"0001678152-26-000003","document":"form4-08102026_100815.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000167815226000003/form4-08102026_100815.xml","form_type":"4"}},{"id":765942,"issuer":{"id":7370,"kind":"organization","name":"ACTUATE THERAPEUTICS, INC."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-05-22T20:04:58.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options will vest in full on the anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":2.42,"expiration_date":"2036-05-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001683168-26-004245","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652935/000168316826004245/ownership.xml","form_type":"4"}},{"id":1135288,"issuer":{"id":7370,"kind":"organization","name":"ACTUATE THERAPEUTICS, INC."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-05-23T20:05:28.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options will vest in full on the anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":10.1,"expiration_date":"2035-05-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001683168-25-003992","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652935/000168316825003992/ownership.xml","form_type":"4"}},{"id":1258539,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:33:39.000Z","date":"2025-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":175000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":0,"derivative":{"exercise_price":1.06,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001415889-25-004756","document":"form4-02202025_120235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000141588925004756/form4-02202025_120235.xml","form_type":"4"}},{"id":1258538,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:33:39.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":175000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":175000,"derivative":{"exercise_price":0.785,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001415889-25-004756","document":"form4-02202025_120235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000141588925004756/form4-02202025_120235.xml","form_type":"4"}},{"id":1258537,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:33:39.000Z","date":"2025-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":0,"derivative":{"exercise_price":3.86,"expiration_date":"2032-01-18","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-25-004756","document":"form4-02202025_120235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000141588925004756/form4-02202025_120235.xml","form_type":"4"}},{"id":1258536,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:33:39.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":125000,"derivative":{"exercise_price":0.785,"expiration_date":"2032-01-18","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-25-004756","document":"form4-02202025_120235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000141588925004756/form4-02202025_120235.xml","form_type":"4"}},{"id":1258535,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:33:39.000Z","date":"2025-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":0,"derivative":{"exercise_price":5.03,"expiration_date":"2031-01-03","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-25-004756","document":"form4-02202025_120235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000141588925004756/form4-02202025_120235.xml","form_type":"4"}},{"id":1258534,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:33:39.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":100000,"derivative":{"exercise_price":0.785,"expiration_date":"2031-01-03","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-25-004756","document":"form4-02202025_120235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000141588925004756/form4-02202025_120235.xml","form_type":"4"}},{"id":1258533,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:33:39.000Z","date":"2025-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":0,"derivative":{"exercise_price":2.45,"expiration_date":"2029-12-09","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001415889-25-004756","document":"form4-02202025_120235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000141588925004756/form4-02202025_120235.xml","form_type":"4"}},{"id":1258532,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:33:39.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":90000,"derivative":{"exercise_price":0.785,"expiration_date":"2029-12-09","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001415889-25-004756","document":"form4-02202025_120235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000141588925004756/form4-02202025_120235.xml","form_type":"4"}},{"id":1258531,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:33:39.000Z","date":"2025-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":70000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":0,"derivative":{"exercise_price":2.45,"expiration_date":"2029-02-12","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001415889-25-004756","document":"form4-02202025_120235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000141588925004756/form4-02202025_120235.xml","form_type":"4"}},{"id":1258530,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:33:39.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":70000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":70000,"derivative":{"exercise_price":0.785,"expiration_date":"2029-02-12","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001415889-25-004756","document":"form4-02202025_120235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000141588925004756/form4-02202025_120235.xml","form_type":"4"}},{"id":1295333,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-24T23:37:21.000Z","date":"2025-01-23","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":0.65,"value":6500.0,"ownership":{"direct":false,"nature":"By The Keyes Trust Dated September 10, 2004"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.62 to $0.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":37720,"source":{"system":"sec-edgar","filing":"0001415889-25-002070","document":"form4-01242025_110117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000141588925002070/form4-01242025_110117.xml","form_type":"4"}},{"id":1309677,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-06T23:11:51.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":175000,"derivative":{"exercise_price":0.77,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001415889-25-000843","document":"form4-01062025_110147.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000141588925000843/form4-01062025_110147.xml","form_type":"4"}},{"id":1309676,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-06T23:11:51.000Z","date":"2024-12-10","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0.54,"value":8100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":88913,"source":{"system":"sec-edgar","filing":"0001415889-25-000843","document":"form4-01062025_110147.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000141588925000843/form4-01062025_110147.xml","form_type":"4"}},{"id":1363125,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-11-15T23:23:19.000Z","date":"2024-11-14","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":0.7,"value":7000.0,"ownership":{"direct":false,"nature":"By The Keyes Trust Dated September 10, 2004"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.67 to $0.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":47720,"source":{"system":"sec-edgar","filing":"0001415889-24-026987","document":"form4-11152024_111115.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000141588924026987/form4-11152024_111115.xml","form_type":"4"}},{"id":1398339,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-27T23:38:23.000Z","date":"2024-09-26","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":0.81,"value":8100.0,"ownership":{"direct":false,"nature":"By The Keyes Trust Dated September 10, 2004"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.79 to $0.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":57720,"source":{"system":"sec-edgar","filing":"0001415889-24-024079","document":"form4-09272024_110919.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000141588924024079/form4-09272024_110919.xml","form_type":"4"}},{"id":1433611,"issuer":{"id":7370,"kind":"organization","name":"ACTUATE THERAPEUTICS, INC."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Options","published_at":"2024-08-14T23:27:32.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"30,000 stock options granted upon the effectiveness of the registration statement for the issuer's initial public offering on August 12, 2024, which vest in three equal installments on the first, second, and third anniversary of the grant date, subject to the reporting person's continued service through each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":8,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-24-089793","document":"tm2421559-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652935/000110465924089793/tm2421559-3_4seq1.xml","form_type":"4"}},{"id":1451628,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-07-18T21:52:35.000Z","date":"2024-07-16","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":0.87,"value":8700.0,"ownership":{"direct":false,"nature":"By The Keyes Trust Dated September 10, 2004"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.82 to $0.9342, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":67720,"source":{"system":"sec-edgar","filing":"0001415889-24-019776","document":"form4-07182024_090731.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000141588924019776/form4-07182024_090731.xml","form_type":"4"}},{"id":1690718,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-03T23:10:31.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":175000,"derivative":{"exercise_price":0.73,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-24-000515","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919124000515/doc4.xml","form_type":"4"}},{"id":1690717,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-03T23:10:31.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":8805,"price":0.58,"value":5106.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":58913,"source":{"system":"sec-edgar","filing":"0001209191-24-000515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919124000515/doc4.xml","form_type":"4"}},{"id":1690716,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-03T23:10:31.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0.56,"value":8400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":50108,"source":{"system":"sec-edgar","filing":"0001209191-24-000515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919124000515/doc4.xml","form_type":"4"}},{"id":2027941,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-07T23:45:31.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":125000,"derivative":{"exercise_price":3.86,"expiration_date":"2032-01-18","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-23-007678","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919123007678/doc4.xml","form_type":"4"}},{"id":2065512,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-04T23:50:33.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":175000,"derivative":{"exercise_price":1.06,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-23-001367","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919123001367/doc4.xml","form_type":"4"}},{"id":2065511,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-04T23:50:33.000Z","date":"2022-12-09","kind":"grant","acquired":true,"shares":4444,"price":1.19,"value":5288.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":35108,"source":{"system":"sec-edgar","filing":"0001209191-23-001367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919123001367/doc4.xml","form_type":"4"}},{"id":2170623,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-30T21:57:48.000Z","date":"2022-08-29","kind":"sale","acquired":false,"shares":7000,"price":2.83,"value":19810.0,"ownership":{"direct":false,"nature":"By The Keyes Trust Dated September 10, 2004"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.80 to $2.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":77720,"source":{"system":"sec-edgar","filing":"0001209191-22-048037","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919122048037/doc4.xml","form_type":"4"}},{"id":2222018,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-06-24T18:29:19.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on June 22, 2022 and vests over one year, with 1/12th of the shares subject to the option vesting at the end of each successive one-month period following the grant date until the earlier of a) the day that is one business day prior to the date of the next annual meeting and b) the first anniversary of the grant date, at which time such option shall be fully vested."}],"balance_after":65000,"derivative":{"exercise_price":0.79,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001485003-22-000082","document":"wf-form4_165610974251502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000148500322000082/wf-form4_165610974251502.xml","form_type":"4"}},{"id":2222017,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-24T18:29:19.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") which shall vest on the first anniversary of the grant date. Each RSU represents a contingent right to receive one share of Sesen Bio, Inc. common stock."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001485003-22-000082","document":"wf-form4_165610974251502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000148500322000082/wf-form4_165610974251502.xml","form_type":"4"}},{"id":2241218,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-07T01:17:34.000Z","date":"2022-06-06","kind":"sale","acquired":false,"shares":5000,"price":2.52,"value":12600.0,"ownership":{"direct":false,"nature":"By The Keyes Trust Dated September 10, 2004"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.48 to $2.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":84720,"source":{"system":"sec-edgar","filing":"0001209191-22-034749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919122034749/doc4.xml","form_type":"4"}},{"id":2303399,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-04-05T21:40:57.000Z","date":"2022-04-04","kind":"sale","acquired":false,"shares":8000,"price":3.18,"value":25440.0,"ownership":{"direct":false,"nature":"By The Keyes Trust Dated September 10, 2004"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $3.12 to $3.25, inclusive.  The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":89720,"source":{"system":"sec-edgar","filing":"0001209191-22-023220","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919122023220/doc4.xml","form_type":"4"}},{"id":2474878,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-13T15:01:37.000Z","date":"2021-12-10","kind":"grant","acquired":true,"shares":5585,"price":2.35,"value":13124.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(c) and Rule 16b-3(d)."}],"balance_after":23296,"source":{"system":"sec-edgar","filing":"0001209191-21-069177","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919121069177/doc4.xml","form_type":"4"}},{"id":2484851,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-03T18:57:54.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":5000,"price":5.0803,"value":25401.5,"ownership":{"direct":false,"nature":"By The Keyes Trust Dated September 10, 2004"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the filer on August 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Volume Weighted Average price of $5.0803. The range of sales prices on the transaction date was $4.750 - $5.320 per share. The reporting person undertakes to provide, upon request of the SEC Staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":97720,"source":{"system":"sec-edgar","filing":"0001209191-21-067752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919121067752/doc4.xml","form_type":"4"}},{"id":2556361,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-29T17:02:22.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":8000,"price":6.7405,"value":53924.0,"ownership":{"direct":false,"nature":"By The Keyes Trust Dated September 10, 2004"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the filer on August 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Volume Weighted Average price of $6.7405. The range of sales prices on the transaction date was $6.58 - $6.88, per share. The reporting person undertakes to provide, upon request of the SEC Staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":102720,"source":{"system":"sec-edgar","filing":"0001209191-21-058029","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919121058029/doc4.xml","form_type":"4"}},{"id":2622698,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-07-28T15:55:49.000Z","date":"2021-07-27","kind":"sale","acquired":false,"shares":5000,"price":5.717,"value":28585.0,"ownership":{"direct":false,"nature":"By The Keyes Trust Dated September 10, 2004"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the filer on August 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Volume Weighted Average price of $5.7170. The range of sales prices on the transaction date was $5.42 - $5.93, per share. The reporting person undertakes to provide, upon request of the SEC Staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":110720,"source":{"system":"sec-edgar","filing":"0001209191-21-048405","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919121048405/doc4.xml","form_type":"4"}},{"id":2669617,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock, par value $0.0001 per share","published_at":"2021-06-14T21:56:13.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":5535,"price":2.35,"value":13007.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(c) and Rule 16b-3(d)."}],"balance_after":17711,"source":{"system":"sec-edgar","filing":"0001209191-21-040314","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919121040314/doc4.xml","form_type":"4"}},{"id":2690623,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-28T23:03:54.000Z","date":"2021-05-26","kind":"sale","acquired":false,"shares":5000,"price":6.4967,"value":32483.5,"ownership":{"direct":false,"nature":"By The Keyes Trust Dated September 10, 2004"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $6.4967. The range of sale prices on the transaction date was $6.40 to $6.59 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."}],"balance_after":115720,"source":{"system":"sec-edgar","filing":"0001209191-21-036674","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919121036674/doc4a.xml","form_type":"4/A","original_submission_date":"2021-05-28"}},{"id":2690622,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-28T22:20:12.000Z","date":"2021-05-26","kind":"sale","acquired":false,"shares":5000,"price":6.4967,"value":32483.5,"ownership":{"direct":false,"nature":"By The Keyes Trust Dated September 10, 2004"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $6.4967. The range of sale prices on the transaction date was $6.40 to $6.59 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."}],"balance_after":115720,"source":{"system":"sec-edgar","filing":"0001209191-21-036648","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919121036648/doc4.xml","form_type":"4"}},{"id":2727117,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-05-05T18:22:34.000Z","date":"2021-05-03","kind":"grant","acquired":true,"shares":92500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on May 3, 2021 and vests over one year, with 1/12th of the shares subject to the option vesting at the end of each successive one-month period following the grant date until the earlier of a) the day that is one business day prior to the date of the next annual meeting and b) the first anniversary of the grant date, at which time such option shall be fully vested. In April 2021, Sesen Bio, Inc.'s compensation committee, based on market analysis by Radford, recommended to the Sesen Bio, Inc. board of directors, and the board of directors approved, an increase in non-employee director equity compensation from the 50th percentile to the 75th percentile of the Radford market analysis of public, pre-commercial biopharmaceutical companies with less than 200 employees and market values between $250 million and $1 billion. The option granted to purchase 92,500 shares of Sesen Bio, Inc.'s common stock was equivalent to the 75th percentile of such Radford market analysis."}],"balance_after":92500,"derivative":{"exercise_price":2.79,"expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":92500},"source":{"system":"sec-edgar","filing":"0001485003-21-000096","document":"wf-form4_162025333944120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000148500321000096/wf-form4_162025333944120.xml","form_type":"4"}},{"id":2914536,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-06T22:00:07.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":100000,"derivative":{"exercise_price":5.03,"expiration_date":"2031-01-03","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-21-002165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919121002165/doc4.xml","form_type":"4"}},{"id":2930766,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-28T14:15:57.000Z","date":"2020-12-23","kind":"sale","acquired":false,"shares":8000,"price":4.7392,"value":37913.6,"ownership":{"direct":false,"nature":"By The Keyes Trust Dated September 10, 2004"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $4.7392. The range of sale prices on the transaction date was $4.68 to $4.83 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."}],"balance_after":120720,"source":{"system":"sec-edgar","filing":"0001209191-20-065139","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919120065139/doc4.xml","form_type":"4"}},{"id":2948039,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-11T22:00:32.000Z","date":"2020-12-10","kind":"other","acquired":true,"shares":5362,"price":2.35,"value":12600.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan."}],"balance_after":12176,"source":{"system":"sec-edgar","filing":"0001209191-20-062993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919120062993/doc4.xml","form_type":"4"}},{"id":3111398,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-12T20:30:12.000Z","date":"2020-06-10","kind":"other","acquired":true,"shares":5014,"price":2.41,"value":12083.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan."}],"balance_after":6814,"source":{"system":"sec-edgar","filing":"0001209191-20-036285","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919120036285/doc4.xml","form_type":"4"}},{"id":3156420,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-05-08T17:52:23.000Z","date":"2020-05-06","kind":"grant","acquired":true,"shares":59000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on May 6, 2020 and vests over one year, with 1/12th of the shares subject to the option vesting at the end of each successive one-month period following the grant date until the earlier of a) the day that is one business day prior to the date of the next annual meeting and b) the first anniversary of the grant date, at which time such option shall be fully vested."}],"balance_after":59000,"derivative":{"exercise_price":0.6294,"expiration_date":"2030-05-06","underlying":"Common Stock","underlying_shares":59000},"source":{"system":"sec-edgar","filing":"0001485003-20-000056","document":"wf-form4_158897472649929.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000148500320000056/wf-form4_158897472649929.xml","form_type":"4"}},{"id":3169910,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-24T21:33:09.000Z","date":"2020-04-22","kind":"grant","acquired":true,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Effective April 22, 2020, the Board of Directors of the Company approved an option repricing which resulted in, for purposes of Section 16 of the Exchange Act, the cancellation of this option granted to him on December 10, 2019, in exchange for a new option having a lower exercise price of $2.45 per share, which is the closing price of the Company's common stock on April 22, 2020.  All of the other terms of the option remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":90000,"derivative":{"exercise_price":2.45,"expiration_date":"2029-12-09","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-20-025659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919120025659/doc4.xml","form_type":"4"}},{"id":3169909,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-24T21:33:09.000Z","date":"2020-04-22","kind":"disposition_to_issuer","acquired":false,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Effective April 22, 2020, the Board of Directors of the Company approved an option repricing which resulted in, for purposes of Section 16 of the Exchange Act, the cancellation of this option granted to him on December 10, 2019, in exchange for a new option having a lower exercise price of $2.45 per share, which is the closing price of the Company's common stock on April 22, 2020.  All of the other terms of the option remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":0,"derivative":{"exercise_price":4.75,"expiration_date":"2029-12-09","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-20-025659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919120025659/doc4.xml","form_type":"4"}},{"id":3169908,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-24T21:33:09.000Z","date":"2020-04-22","kind":"grant","acquired":true,"shares":70000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Effective April 22, 2020, the Board of Directors of the Company approved an option repricing which resulted in, for purposes of Section 16 of the Exchange Act, the cancellation of this option granted to him on February 13, 2019, in exchange for a new option having a lower exercise price of $2.45 per share, which is the closing price of the Company's common stock on April 22, 2020.  All of the other terms of the option remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":70000,"derivative":{"exercise_price":2.45,"expiration_date":"2029-02-12","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001209191-20-025659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919120025659/doc4.xml","form_type":"4"}},{"id":3169907,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-24T21:33:09.000Z","date":"2020-04-22","kind":"disposition_to_issuer","acquired":false,"shares":70000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Effective April 22, 2020, the Board of Directors of the Company approved an option repricing which resulted in, for purposes of Section 16 of the Exchange Act, the cancellation of this option granted to him on February 13, 2019, in exchange for a new option having a lower exercise price of $2.45 per share, which is the closing price of the Company's common stock on April 22, 2020.  All of the other terms of the option remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":0,"derivative":{"exercise_price":7.16,"expiration_date":"2029-02-12","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001209191-20-025659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919120025659/doc4.xml","form_type":"4"}},{"id":3246301,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-02-26T17:25:21.000Z","date":"2020-02-24","kind":"grant","acquired":true,"shares":118000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on February 24, 2020 and vests monthly in equal amounts over a three-year period following the grant date."}],"balance_after":118000,"derivative":{"exercise_price":0.8224,"expiration_date":"2030-02-24","underlying":"Common Stock","underlying_shares":118000},"source":{"system":"sec-edgar","filing":"0001485003-20-000030","document":"wf-form4_158275590275256.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000148500320000030/wf-form4_158275590275256.xml","form_type":"4"}},{"id":3261825,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-02-19T22:48:19.000Z","date":"2020-02-18","kind":"sale","acquired":false,"shares":5000,"price":5.0275,"value":25137.5,"ownership":{"direct":false,"nature":"By The Keyes Trust Dated September 10, 2004"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":130520,"source":{"system":"sec-edgar","filing":"0001209191-20-010740","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919120010740/doc4.xml","form_type":"4"}},{"id":3305016,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-23T01:13:52.000Z","date":"2020-01-21","kind":"sale","acquired":false,"shares":5000,"price":4.4086,"value":22043.0,"ownership":{"direct":false,"nature":"By The Keyes Trust Dated September 10, 2004"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.21 to $4.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,800 shares acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan on December 10, 2019."}],"balance_after":135520,"source":{"system":"sec-edgar","filing":"0001209191-20-004544","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919120004544/doc4.xml","form_type":"4"}},{"id":3343331,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-12-12T22:57:46.000Z","date":"2019-12-10","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":90000,"derivative":{"exercise_price":4.75,"expiration_date":"2029-12-09","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-19-060269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919119060269/doc4.xml","form_type":"4"}},{"id":3422814,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-09-04T21:35:31.000Z","date":"2019-09-03","kind":"sale","acquired":false,"shares":5000,"price":3.5961,"value":17980.5,"ownership":{"direct":false,"nature":"By The Keyes Trust Dated September 10, 2004"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $3.55 to $3.68, inclusive.  The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":138720,"source":{"system":"sec-edgar","filing":"0001209191-19-048262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919119048262/doc4.xml","form_type":"4"}},{"id":3446538,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-05T21:04:59.000Z","date":"2019-08-01","kind":"sale","acquired":false,"shares":5000,"price":3.9882,"value":19941.0,"ownership":{"direct":false,"nature":"By The Keyes Trust Dated September 10, 2004"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $3.85 to $4.16, inclusive.  The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":143720,"source":{"system":"sec-edgar","filing":"0001209191-19-044617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919119044617/doc4.xml","form_type":"4"}},{"id":3653102,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-15T23:23:55.000Z","date":"2019-02-13","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":70000,"derivative":{"exercise_price":7.16,"expiration_date":"2029-02-12","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001209191-19-010768","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678152/000120919119010768/doc4.xml","form_type":"4"}},{"id":4184570,"issuer":{"id":157016,"kind":"organization","name":"Orexigen Therapeutics, Inc.","symbol":"OREXQ"},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2017-10-17T19:19:27.000Z","date":"2017-10-13","kind":"grant","acquired":true,"shares":69600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an award of restricted stock units (\"RSUs\"), each representing a contingent right to receive a share of the issuer's common stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-five percent (25%) of the RSUs will vest on each of the first four (4) anniversaries of February 3, 2018 (each, a \"Vesting Date\"), subject to the reporting person's continued eligibility on each applicable Vesting Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Twenty-five percent (25%) of the RSUs will vest on each of the first four (4) anniversaries of February 3, 2018 (each, a \"Vesting Date\"), subject to the reporting person's continued eligibility on each applicable Vesting Date."}],"balance_after":69600,"derivative":{"underlying":"Common Stock","underlying_shares":69600},"source":{"system":"sec-edgar","filing":"0001209191-17-057220","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1382911/000120919117057220/doc4.xml","form_type":"4"}},{"id":4295255,"issuer":{"id":157016,"kind":"organization","name":"Orexigen Therapeutics, Inc.","symbol":"OREXQ"},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-06-02T16:44:00.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":557,"price":1.55,"value":863.35,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Shares acquired under Issuer's 2013 Employee Stock Purchase Plan."}],"balance_after":3031,"source":{"system":"sec-edgar","filing":"0001209191-17-037324","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1382911/000120919117037324/doc4.xml","form_type":"4"}},{"id":4463658,"issuer":{"id":157016,"kind":"organization","name":"Orexigen Therapeutics, Inc.","symbol":"OREXQ"},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Stock Option","published_at":"2017-02-07T06:48:23.000Z","date":"2017-02-03","kind":"grant","acquired":true,"shares":43500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not Applicable"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares of stock subject to the option (rounded down to the next whole number of shares) shall vest on the same day of each month following 2/3/2017, so that all of the shares of the stock subject to the option shall be vested on 2/3/2021, subject to the Reporting Person's continued service relationship (whether as an employee, director or consultant) with the Issuer or any parent or subsidiary on each such date, as set forth in the applicable stock option grant notice and stock option agreement for such Reporting Person."}],"balance_after":43500,"derivative":{"exercise_price":15,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":43500},"source":{"system":"sec-edgar","filing":"0001209191-17-008200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1382911/000120919117008200/doc4.xml","form_type":"4"}},{"id":4463657,"issuer":{"id":157016,"kind":"organization","name":"Orexigen Therapeutics, Inc.","symbol":"OREXQ"},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Stock Option","published_at":"2017-02-07T06:48:23.000Z","date":"2017-02-03","kind":"grant","acquired":true,"shares":87000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not Applicable"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares of stock subject to the option (rounded down to the next whole number of shares) shall vest on the same day of each month following 2/3/2017, so that all of the shares of the stock subject to the option shall be vested on 2/3/2021, subject to the Reporting Person's continued service relationship (whether as an employee, director or consultant) with the Issuer or any parent or subsidiary on each such date, as set forth in the applicable stock option grant notice and stock option agreement for such Reporting Person."}],"balance_after":87000,"derivative":{"exercise_price":4.1,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":87000},"source":{"system":"sec-edgar","filing":"0001209191-17-008200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1382911/000120919117008200/doc4.xml","form_type":"4"}},{"id":4535001,"issuer":{"id":157016,"kind":"organization","name":"Orexigen Therapeutics, Inc.","symbol":"OREXQ"},"owners":[{"id":25050,"kind":"person","name":"Keyes Jason A","position":1,"cik":"0001678152","reported_name":"Keyes Jason A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2016-12-02T17:10:15.000Z","date":"2016-11-30","kind":"grant","acquired":true,"shares":291,"price":1.67,"value":485.97,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Shares acquired under Issuer's 2013 Employee Stock Purchase Plan."}],"balance_after":2474,"source":{"system":"sec-edgar","filing":"0001209191-16-153092","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1382911/000120919116153092/doc4.xml","form_type":"4"}}]}